Adiponectin in Youth
- 1 February 2004
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 27 (2) , 547-552
- https://doi.org/10.2337/diacare.27.2.547
Abstract
Adiponectin is an adipose tissue protein that enhances insulin sensitivity and has antiatherogenic properties. The present study investigated the relationship of adiponectin levels in adolescents to 1) obesity and body fat distribution and 2) insulin sensitivity and the components of syndrome X. Twenty-three normal-weight and 26 obese adolescents had fasting adiponectin, lipid profile, and proinsulin measurements performed. Hepatic and peripheral insulin sensitivity were assessed with constant-rate [6,6-(2)H(2)]glucose infusion and a 3-h hyperinsulinemic-euglycemic clamp, respectively. Body composition was evaluated by dual-energy X-ray absorptiometry, and visceral adipose tissue (VAT) and subcutaneous adipose tissue were measured by computed tomography scan at the L(4)-L(5) level. Obese adolescents had approximately 50% lower adiponectin than normal-weight adolescents. Moreover, obese adolescents with high (111.8 +/- 9.3 cm(2)) versus low (55.4 +/- 2.1 cm(2)) VAT had lower adiponectin levels (6.2 +/- 0.9 vs. 9.0 +/- 1.0 microg/ml, P = 0.05). Plasma adiponectin correlated positively with peripheral and hepatic insulin sensitivity (r = 0.67, P < 0.001 and r = 0.54, P < 0.001, respectively) and HDL (r = 0.52, P < 0.001) and negatively with fasting proinsulin and the proinsulin-to-insulin ratio (r = -0.64, P < 0.001 and r = -0.43, P = 0.003, respectively). In a multiple regression analysis, adiponectin, independently and together with BMI, explained 73% (R(2) = 0.73, P < 0.001) of the variance in insulin sensitivity. Adiponectin, but not adiposity, was the significant independent determinant of the proinsulin-to-insulin ratio (R(2) = 0.18, P = 0.008) and of HDL (R(2) = 0.45, P < 0.001). In summary, hypoadiponectinemia in youth is a strong and independent correlate of insulin resistance, beta-cell dysfunction, visceral adiposity, and syndrome X. The antidiabetogenic and antiatherogenic properties of adiponectin are evident early in life and compromised in youth-onset obesity.Keywords
This publication has 35 references indexed in Scilit:
- Decreased Plasma Adiponectin Concentrations in Women with DyslipidemiaJournal of Clinical Endocrinology & Metabolism, 2002
- Dihydrotestosterone Treatment in Adolescents with Delayed Puberty: Does it Explain Insulin Resistance of Puberty?Journal of Clinical Endocrinology & Metabolism, 2001
- Weight Reduction Increases Plasma Levels of an Adipose-Derived Anti-Inflammatory Protein, AdiponectinJournal of Clinical Endocrinology & Metabolism, 2001
- Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and HyperinsulinemiaJournal of Clinical Endocrinology & Metabolism, 2001
- Glucose Intolerance in Obese Adolescents with Polycystic Ovary Syndrome: Roles of Insulin Resistance and -Cell Dysfunction and Risk of Cardiovascular DiseaseJournal of Clinical Endocrinology & Metabolism, 2001
- Relative Hyperproinsulinemia as a Sign of Islet Dysfunction in Women with Impaired Glucose ToleranceJournal of Clinical Endocrinology & Metabolism, 1999
- Disproportionately Elevated Proinsulin Levels Reflect the Degree of Impaired B Cell Secretory Capacity in Patients with Noninsulin-Dependent Diabetes MellitusJournal of Clinical Endocrinology & Metabolism, 1998
- Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDMDiabetes, 1997
- cDNA Cloning and Expression of a Novel Adipose Specific Collagen-like Factor, apM1 (AdiposeMost Abundant Gene Transcript 1)Biochemical and Biophysical Research Communications, 1996
- Proinsulin as a marker for the development of NIDDM in Japanese-American menDiabetes, 1995